Life Sciences News @ Gowlings

	Life Sciences News @ Gowlings
	September 3, 2010

Use Twitter? Follow Gowlings news on Twitter

Celgene seeks to stop Natco's generic Revlimid
http://www.reuters.com/article/idUSN0326933120100903

Celldex says Pfizer ends cancer vaccine deal; shrs fall
http://www.reuters.com/article/idUSSGE6820ET20100903

Pfizer to buy FoldRx Pharma
http://www.pharmatimes.com/Article/10-09-02/Pfizer_to_buy_FoldRx_Pharma.aspx

Roche to cut costs across group, coy on job cut numbers
http://www.pharmatimes.com/Article/10-09-03/Roche_to_cut_costs_across_group_coy_on_job_cut_numbers.aspx

Takeda and Orexigen sign $1 billion obesity pact
http://www.pharmatimes.com/Article/10-09-03/Takeda_and_Orexigen_sign_1_billion_obesity_pact.aspx

LifeSciences British Columbia Appoints Don Enns as President
http://www.financialpost.com/markets/news/LifeSciences+British+Columbia+Appoints+Enns+President/3464151/story.html

Deep-fried beer invented in Texas
http://www.telegraph.co.uk/foodanddrink/foodanddrinknews/7973944/Deep-fried-beer-invented-in-Texas.html

Life Sciences News @ Gowlings is a daily news service that provides news items of interest to those in the life sciences.

At any time, you can amend your subscriptions with Gowlings by visiting our website (subscribe | unsubscribe). By your use of this service you agree to the Terms of Use. If you do not agree with the Terms of Use, please do not use the service.

Please contact LifeSciencesNews@gowlingsnewsletters.com with questions or comments.

Gowlings and Personal Information - Gowlings respects your privacy. Please see Gowlings' Privacy Policy for more information about how our Firm manages your personal information.

Gowlings is an acknowledged leader in business law, technology law, intellectual property and advocacy.

© 2010 Gowling Lafleur Henderson LLP. All rights reserved.